GLP-1 Drug Coverage in Canada
US$ 23.90
glp-1 agonist structure Crystal of the receptor bound to a peptide Molecular insights into ago-allosteric modulation
Description
Understanding their distinct mechanisms, clinical evidence bases, and how genetic and biomarker data inform personalized treatment selection helps patients and providers make evidence-based decisions
Do not reuse
Commonly prescribed GLP-1RAs: Exenatide (Byetta, Bydureon) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Semaglutide (Ozempic, Wegovy, Rybelsus) Tirzepatide (Mounjaro) Study overview: What was investigated
Shima Hadidchi, MD, in Apple Valley and Victorville, CA
Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes
